Metraipolis › archive › dc_609cef0fff37

Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD &… — Europe PMC PMID:41849243

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41849243
DOI
10.1093/ibd/izag017
License (as archived)
solo-consultazione
Archived
2026-10-18T13:49:20.849Z
SHA-256 of the archived text
2db0a52397eac639c8e39e3d1c43b4de5f38cf479753a889de67768538fedfcf
Stable URL of this page
https://metraipolis.com/documento/dc_609cef0fff37

How to cite

Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD &… — Europe PMC PMID:41849243 — Europe PMC (en), https://europepmc.org/article/MED/41849243 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_609cef0fff37 (Metraipolis archive dc_609cef0fff37, sha256 2db0a52397eac639c8e39e3d1c43b4de5f38cf479753a889de67768538fedfcf)
BibTeX
@misc{dc609cef0fff37,
  title = {Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD &… — Europe PMC PMID:41849243},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41849243},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_609cef0fff37; sha256 2db0a52397eac639c8e39e3d1c43b4de5f38cf479753a889de67768538fedfcf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41849243. Agents can read the archived copy with the MCP tool read_document.